6.845 USD
-0.37 (-5.19%)
Taking everything into account, SENS scores 2 out of 10 in our fundamental rating. SENS was compared to 185 industry peers in the Health Care Equipment & Supplies industry. SENS scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. SENS is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year SENS has reported negative net income.
In the past year SENS has reported a negative cash flow from operations.
SENS had negative earnings in 4 of the past 5 years.
SENS had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
With a Return On Assets value of -45.39%, SENS is not doing good in the industry: 64.86% of the companies in the same industry are doing better.
SENS has a Return On Equity (-72.01%) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -45.39% | ||
| ROE | -72.01% | ||
| ROIC | N/A |
ROA(3y)-13.99%
ROA(5y)-136.34%
ROE(3y)-16.55%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
The Gross Margin of SENS (17.77%) is worse than 79.46% of its industry peers.
SENS does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 17.77% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
SENS does not have a ROIC to compare to the WACC, probably because it is not profitable.
SENS has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, SENS has more shares outstanding
The debt/assets ratio for SENS is higher compared to a year ago.
2.2 Solvency
SENS has an Altman-Z score of -6.16. This is a bad value and indicates that SENS is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -6.16, SENS is doing worse than 72.43% of the companies in the same industry.
SENS has a Debt/Equity ratio of 0.37. This is a healthy value indicating a solid balance between debt and equity.
With a Debt to Equity ratio value of 0.37, SENS perfoms like the industry average, outperforming 48.11% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.37 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -6.16 |
ROIC/WACCN/A
WACC10.23%
2.3 Liquidity
SENS has a Current Ratio of 9.58. This indicates that SENS is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of SENS (9.58) is better than 90.27% of its industry peers.
SENS has a Quick Ratio of 9.26. This indicates that SENS is financially healthy and has no problem in meeting its short term obligations.
SENS's Quick ratio of 9.26 is amongst the best of the industry. SENS outperforms 91.89% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 9.58 | ||
| Quick Ratio | 9.26 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 37.31% over the past year.
Looking at the last year, SENS shows a small growth in Revenue. The Revenue has grown by 0.37% in the last year.
Measured over the past years, SENS shows a small growth in Revenue. The Revenue has been growing by 1.08% on average per year.
EPS 1Y (TTM)37.31%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%46.25%
Revenue 1Y (TTM)0.37%
Revenue growth 3Y18.01%
Revenue growth 5Y1.08%
Sales Q2Q%89.89%
3.2 Future
The Earnings Per Share is expected to grow by 8.91% on average over the next years. This is quite good.
SENS is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 53.85% yearly.
EPS Next Y36.15%
EPS Next 2Y1.96%
EPS Next 3Y5.01%
EPS Next 5Y8.91%
Revenue Next Year59.44%
Revenue Next 2Y64.87%
Revenue Next 3Y58%
Revenue Next 5Y53.85%
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for SENS. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for SENS. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y1.96%
EPS Next 3Y5.01%
5. Dividend
5.1 Amount
SENS does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
NASDAQ:SENS (1/12/2026, 10:24:15 AM)
6.845
-0.37 (-5.19%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners15.44%
Inst Owner Change-0.15%
Ins Owners2.77%
Ins Owner Change0.13%
Market Cap279.69M
Revenue(TTM)22.47M
Net Income(TTM)-68.21M
Analysts75.71
Price Target19.3 (181.96%)
Short Float %9.78%
Short Ratio5.83
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)8.35%
Min EPS beat(2)1.96%
Max EPS beat(2)14.75%
EPS beat(4)3
Avg EPS beat(4)9.2%
Min EPS beat(4)-14%
Max EPS beat(4)34.09%
EPS beat(8)6
Avg EPS beat(8)7.97%
EPS beat(12)7
Avg EPS beat(12)-1.14%
EPS beat(16)11
Avg EPS beat(16)63.15%
Revenue beat(2)2
Avg Revenue beat(2)9.27%
Min Revenue beat(2)8.25%
Max Revenue beat(2)10.29%
Revenue beat(4)4
Avg Revenue beat(4)6.13%
Min Revenue beat(4)2.48%
Max Revenue beat(4)10.29%
Revenue beat(8)7
Avg Revenue beat(8)5.36%
Revenue beat(12)10
Avg Revenue beat(12)4.93%
Revenue beat(16)11
Avg Revenue beat(16)2.84%
PT rev (1m)0%
PT rev (3m)1222.85%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-1426.9%
EPS NY rev (1m)0%
EPS NY rev (3m)-1884.32%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.81%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-2.1%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 10.98 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 2.95 | ||
| P/tB | 2.98 | ||
| EV/EBITDA | N/A |
EPS(TTM)-1.63
EYN/A
EPS(NY)-2.3
Fwd EYN/A
FCF(TTM)-1.34
FCFYN/A
OCF(TTM)-1.33
OCFYN/A
SpS0.62
BVpS2.32
TBVpS2.3
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -45.39% | ||
| ROE | -72.01% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 17.77% | ||
| FCFM | N/A |
ROA(3y)-13.99%
ROA(5y)-136.34%
ROE(3y)-16.55%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.17
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.37 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 22.67% | ||
| Cap/Sales | 1.53% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 9.58 | ||
| Quick Ratio | 9.26 | ||
| Altman-Z | -6.16 |
F-Score5
WACC10.23%
ROIC/WACCN/A
Cap/Depr(3y)70.29%
Cap/Depr(5y)48.74%
Cap/Sales(3y)4.48%
Cap/Sales(5y)3.72%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)37.31%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%46.25%
EPS Next Y36.15%
EPS Next 2Y1.96%
EPS Next 3Y5.01%
EPS Next 5Y8.91%
Revenue 1Y (TTM)0.37%
Revenue growth 3Y18.01%
Revenue growth 5Y1.08%
Sales Q2Q%89.89%
Revenue Next Year59.44%
Revenue Next 2Y64.87%
Revenue Next 3Y58%
Revenue Next 5Y53.85%
EBIT growth 1Y11.96%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year28.8%
EBIT Next 3Y-10.15%
EBIT Next 5YN/A
FCF growth 1Y21.67%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y22.05%
OCF growth 3YN/A
OCF growth 5YN/A
SENSEONICS HOLDINGS INC / SENS FAQ
Can you provide the ChartMill fundamental rating for SENSEONICS HOLDINGS INC?
ChartMill assigns a fundamental rating of 2 / 10 to SENS.
Can you provide the valuation status for SENSEONICS HOLDINGS INC?
ChartMill assigns a valuation rating of 0 / 10 to SENSEONICS HOLDINGS INC (SENS). This can be considered as Overvalued.
What is the profitability of SENS stock?
SENSEONICS HOLDINGS INC (SENS) has a profitability rating of 0 / 10.
What is the financial health of SENSEONICS HOLDINGS INC (SENS) stock?
The financial health rating of SENSEONICS HOLDINGS INC (SENS) is 4 / 10.